Herpes Labialis (Oral Herpes) drugs in development, 2023

GlobalData tracks 15 drugs in development for Herpes Labialis (Oral Herpes) by 11 companies/universities/institutes. The top development phase for Herpes Labialis (Oral Herpes) is preclinical, with six drugs in that stage.

GE HealthCare imaging CEO Jan Makela talks Mayo Clinic partnership

GE HealthCare and Mayo Clinic reached an agreement earlier this month to work together on medical technology, building on past work between the two companies that

October 6, 2023

Stable Schizophrenia Not Necessarily Protective Against Relapse-Related Mortality

Just one relapse episode significantly increased all-cause mortality in people with relatively stable schizophrenia, a longitudinal study of database claims indicated. Among 32,071 patients followed

November 4, 2024

New brain biomarker identifies pain sensitivity and may predict chronic pain risk

A novel biomarker signature combining PAF and CME predicts chronic pain risk, linking brain activity to individual pain sensitivity and treatment strategies.

January 28, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.